252 related articles for article (PubMed ID: 29248119)
1. [Hyponatremia associated with SSRI/NRSI: Descriptive and comparative epidemiological study of the incidence rates of the notified cases from the data of the French National Pharmacovigilance Database and the French National Health Insurance].
Revol R; Rault C; Polard E; Bellet F; Guy C
Encephale; 2018 Jun; 44(3):291-296. PubMed ID: 29248119
[TBL] [Abstract][Full Text] [Related]
2. Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs.
Giorlando F; Teister J; Dodd S; Udina M; Berk M
Curr Drug Saf; 2013 Jul; 8(3):175-80. PubMed ID: 23841535
[TBL] [Abstract][Full Text] [Related]
3. SSRI/SNRI -induced Hyponatremia: A Case Series of 26 Patients in a Single Institution from 2018 to 2020.
Zhao Z; Zhao F; Jin P; Hu X; Tian C; Liu D; Zhang Y
Psychiatr Q; 2023 Jun; 94(2):113-125. PubMed ID: 36913163
[TBL] [Abstract][Full Text] [Related]
4. [Antidepressive agents and hyponatremia: A literature review and a case/non-case study in the French Pharmacovigilance database].
Rochoy M; Zakhem-Stachera C; Béné J; Berkhout C; Gautier S;
Therapie; 2018 Oct; 73(5):389-398. PubMed ID: 29773358
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
[TBL] [Abstract][Full Text] [Related]
6. [Drug induced hyponatremia. About a series of 54 cases notified to the regional center of pharmacovigilance of Saint-Étienne].
Fenoglio I; Guy C; Beyens MN; Mounier G; Marsille F; Mismetti P
Therapie; 2011; 66(2):139-48. PubMed ID: 21635862
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.
Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M
CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758
[TBL] [Abstract][Full Text] [Related]
8. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
Lin ND; Norman H; Regev A; Perahia DG; Li H; Chang CL; Dore DD
BMC Gastroenterol; 2015 Oct; 15():134. PubMed ID: 26467777
[TBL] [Abstract][Full Text] [Related]
9. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
[TBL] [Abstract][Full Text] [Related]
10. Concomitant triptan and SSRI or SNRI use: a risk for serotonin syndrome.
Sclar DA; Robison LM; Skaer TL
Headache; 2008 Jan; 48(1):126-9. PubMed ID: 18005139
[TBL] [Abstract][Full Text] [Related]
11. Hyponatremia Induced by Duloxetine: A Case Report.
Hu D; Wurster S
Consult Pharm; 2018 Aug; 33(8):446-449. PubMed ID: 30068437
[TBL] [Abstract][Full Text] [Related]
12. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults.
Jacob S; Spinler SA
Ann Pharmacother; 2006 Sep; 40(9):1618-22. PubMed ID: 16896026
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
14. Hyponatremia-associated hospital visits are not reduced by early electrolyte testing in older adults starting antidepressants.
Lane NE; Bai L; Seitz DP; Juurlink DN; Paterson JM; Guan J; Stukel TA
J Am Geriatr Soc; 2024 Jun; 72(6):1770-1780. PubMed ID: 38662854
[TBL] [Abstract][Full Text] [Related]
15. Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance-Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Mazhar F; Pozzi M; Gentili M; Scatigna M; Clementi E; Radice S; Carnovale C
CNS Drugs; 2019 Jun; 33(6):581-592. PubMed ID: 30977109
[TBL] [Abstract][Full Text] [Related]
16. Acute Hyponatremia Resulting from Duloxetine-induced Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Yoshida K; Aburakawa Y; Suzuki Y; Kuroda K; Kimura T
Intern Med; 2019 Jul; 58(13):1939-1942. PubMed ID: 30799365
[TBL] [Abstract][Full Text] [Related]
17. A case of hyponatremia induced by duloxetine.
Safdieh JE; Rudominer R
J Clin Psychopharmacol; 2006 Dec; 26(6):675-6. PubMed ID: 17110834
[No Abstract] [Full Text] [Related]
18. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: A systematic review and meta-analysis.
Khanassov V; Hu J; Reeves D; van Marwijk H
Int J Geriatr Psychiatry; 2018 Dec; 33(12):1688-1708. PubMed ID: 30247774
[TBL] [Abstract][Full Text] [Related]
19. Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
Orlova Y; Rizzoli P; Loder E
JAMA Neurol; 2018 May; 75(5):566-572. PubMed ID: 29482205
[TBL] [Abstract][Full Text] [Related]
20. Channelling of SSRIs and SNRIs use in the Tayside population, Scotland.
Wei L; Chen R; MacDonald TM
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):859-66. PubMed ID: 17523184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]